Cerebain Biotech Appoints Dr. Saini Chairman of Its Scientific Advisory Board
6/18/2013 9:30:00 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO) announced today the appointment of Dr. Surinder Saini as Chairman of its Scientific Advisory Board. The advisory board provides key clinical insight into the company’s efforts to develop and commercialize a novel approach to the treatment for patients suffering from Alzheimer’s disease. Dr. Saini is the lead scientist behind the development of the world's first medical device specifically designed for the treatment of Alzheimer’s disease utilizing the Omentum.
Help employers find you! Check out all the jobs and post your resume.
comments powered by